Cited by 820Nerve injury and regenerationAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Allen, Shelley J., Watson, Judy J., Shoemark, Deborah K., Barua, Neil U., Patel, Nikunj K.·2013·Pharmacology & Therapeutics

DOI 10.1016/j.pharmthera.2013.01.004

Open this paper in CoChat — free account

Abstract

Glial cell-derived neurotrophic factor (GDNF), and the neurotrophin nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are important for the survival, maintenance and regeneration of specific neuronal populations in the adult brain. Depletion of these neurotrophic factors has been linked with disease pathology and symptoms, and replacement strategies are considered as potential therapeutics for neurodegenerative diseases such as Parkinson's, Alzheimer's and Huntington's diseases. GDNF administration has recently been shown to be an effective treatment for Parkinson's disease, with clinical trials currently in progress. Trials with NGF for Alzheimer's disease are ongoing, with some degree of success. Preclinical results using BDNF also show much promise, although there are accompanying difficulties. Ultimately, the administration of a therapy involving proteins in the brain has inherent problems. Because of the blood-brain-barrier, the protein must be infused directly, produced by viral constructs, secreted from implanted protein-secreting cells or actively transported across the brain. An alternative to this is the use of a small molecule agonist, a modulator or enhancer targeting the associated receptors. We evaluate these neurotrophic factors as potential short or long-term treatments, weighing up preclinical and clinical results with the possible effects on the underlying neurodegenerative process.

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2013.01.004

Cites

256 of 256 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–256 of 256

Glial cell line-derived neurotrophic factor induces the dopaminergic and cholinergic phenotype and increases locomotor activity in aged Fischer 344 rats
Lapchak, P. A., Miller, P. J., & Jiao, S. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00492-7 · Cited by 74
Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine
for the German Competence Network HIV/AIDS, Meisner, F., Scheller, C., Kneitz, S., Sopper, S., Neuen-Jacob, E., Riederer, P., Meulen, V. T., & Koutsilieri, E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301615 · Cited by 73
Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys
Maswood, N., Grondin, R., Zhang, Z., Stanford, J. A., Surgener, S. P., Gash, D. M., & Gerhardt, G. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00022-2 · Cited by 70
Increases in Two Truncated TrkB Isoforms in the Prefrontal Cortex of People With Schizophrenia
Wong, J., Rothmond, D. A., Webster, M. J., & Weickert, C. S. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr070 · Cited by 69
Selective Small Molecule Peptidomimetic Ligands of TrkC and TrkA Receptors Afford Discrete or Complete Neurotrophic Activities
Zaccaro, M. C., Lee, H. B., Pattarawarapan, M., Xia, Z., Caron, A. W., L’Heureux, P.-J., Bengio, Y., Burgess, K., & Saragovi, H. U. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.06.015 · Cited by 67
Hyperplastic Changes within the Leptomeninges of the Rat and Monkey in Response to Chronic Intracerebroventricular Infusion of Nerve Growth Factor
Day-Lollini, P. A., Stewart, G. R., Taylor, M. J., Johnson, R. M., & Chellman, G. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6448 · Cited by 67
Modulation of p75NTR‐dependent motor neuron death by a small non‐peptidyl mimetic of the neurotrophin loop 1 domain
Pehar, M., Cassina, P., Vargas, M. R., Xie, Y., Beckman, J. S., Massa, S. M., Longo, F. M., & Barbeito, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05040.x · Cited by 67
Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity
Scarpi, D., Cirelli, D. J., Matrone, C., Castronovo, G., Rosini, P., Occhiato, E. G., Romano, F., Bartali, L., Clemente, A. M., Bottegoni, G., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.80 · Cited by 67
Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression
Blesch, A., Conner, J. M., & Tuszynski, M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301480 · Cited by 66
Intracerebroventricular Glial Cell Line-Derived Neurotrophic Factor Improves Motor Function and Supports Nigrostriatal Dopamine Neurons in Bilaterally 6-Hydroxydopamine Lesioned Rats
Bowenkamp, K. E., Lapchak, P. A., Hoffer, B. J., Miller, P. J., & Bickford, P. C. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6436 · Cited by 65
Cytoprotective effects of growth factors: BDNF more potent than GDNF in an organotypic culture model of Parkinson's disease
Stahl, K., Mylonakou, M. N., Skare, Ø., Amiry-Moghaddam, M. R., & Torp, R. (2011) · Brain Research · doi:10.1016/j.brainres.2010.12.090 · Cited by 63
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats
Grandoso, L., Márquez, S. P., Manuel, I., Arrúe, A., Ruíz-Ortega, J. Á., Ulibarri, I., Orive, G., Hernández, R. M., RODRIGUEZ, A., & Rodríguez‐Puertas, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.027 · Cited by 63
Expression of mRNAs for Neurotrophins (NGF, BDNF, and NT-3) and their Receptors (p75NGFR, Trk, TrkB, and TrkC) in Human Peripheral Neuropathies
Sobue, G., Yamamoto, M., Doyu, M., Li, M., Yasuda, T., & Mitsuma, T. (1998) · Neurochemical Research · doi:10.1023/a:1022434209787 · Cited by 62
GDNF reverses priming for dyskinesia in MPTP‐treated, l ‐DOPA‐primed common marmosets
Iravani, M. M., Costa, S., Jackson, M. J., Tel, B. C., Cannizzaro, C., Pearce, R. K. B., & Jenner, P. G. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01408.x · Cited by 59
Effect of p75 neurotrophin receptor antagonist on disease progression in transgenic amyotrophic lateral sclerosis mice
Turner, B. J., Murray, S. S., Piccenna, L. G., Lopes, E. C., Kilpatrick, T. J., & Cheema, S. S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20256 · Cited by 59
Unilateral intraputaminal glial cell line–derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal
Slevin, J. T., Gash, D. M., Smith, C. D., Gerhardt, G. A., Kryscio, R. J., Chebrolu, H., Walton, A., Wagner, R. P., & Young, A. B. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.5.2 · Cited by 58
Image-guided convection-enhanced delivery of GDNF protein into monkey putamen
Gimenez, F., Krauze, M. T., Valles, F. E., Hadaczek, P., Bringas, J., Sharma, N., Forsayeth, J., & Bankiewicz, K. S. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.023 · Cited by 57
BDNF is induced by wild-type α-synuclein but not by the two mutants, A30P or A53T, in glioma cell line
Kohno, R., Sawada, H., Kawamoto, Y., Uemura, K., Shibasaki, H., & Shimohama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.012 · Cited by 57
Neurotrophic Factors in the Pathogenesis of Rett Syndrome
Riikonen, R. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180101101 · Cited by 56
Improving Safety of Gene Therapy
Ylä‐Herttuala, S., Räty, J. K., Lesch, H. P., et al. (2008) · Current Drug Safety · doi:10.2174/157488608783333925 · Cited by 56
Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets
Costa, S., Iravani, M. M., Pearce, R. K. B., & Jenner, P. G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00933-x · Cited by 56
Low Levels of Nerve Growth Factor in Cerebrospinal Fluid of Children With Rett Syndrome
Lappalainen, R., Lindholm, D., & Riikonen, R. (1996) · Journal of Child Neurology · doi:10.1177/088307389601100407 · Cited by 54
The TNF ligand superfamily and its relevance for human diseases.
Gruss, H. J., & Dower, S. (1995) · PubMed · Cited by 54
Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis
Nishio, T., Sunohara, N., & Furukawa, S. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00073 · Cited by 53
Functional mimetics of neurotrophins and their receptors
Peleshok, J. C., & Saragovi, H. U. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340612 · Cited by 51
Identification of a Novel Prohormone Sorting Signal-Binding Site on Carboxypeptidase E, a Regulated Secretory Pathway-Sorting Receptor
Zhang, C., Snell, C. R., & Loh, Y. P. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.4.0267 · Cited by 50
Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats
Martin, D. A., Miller, G., Cullen, T., Fischer, N., Dix, D., & Russell, D. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00756-x · Cited by 50
Distribution of β‐nerve growth factor receptors in the human basal forebrain
Allen, S. J., Dawbarn, D., Spillantini, M. G., Goedert, M., Wilcock, G. K., Moss, T. H., & Semenenko, F. M. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902890408 · Cited by 49
Self-citation
Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
Garbayo, E., Ansorena, E., Lanciego, J. L., Blanco‐Prieto, M. J., & Aymerich, M. S. (2011) · Movement Disorders · doi:10.1002/mds.23793 · Cited by 47
The role of neurotransmission and the Chopper domain in p75 neurotrophin receptor death signaling
Coulson, E. J., Reid, K., Shipham, K. M., Morley, S., Kilpatrick, T. J., & Bartlett, P. F. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)46003-2 · Cited by 46
Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome
Riikonen, R., & Vanhala, R. (1999) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162299000328 · Cited by 46
Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon
Studer, L., Spenger, C., Seiler, R. D., Othberg, A. I., Lindvall, O., & Odin, P. (1996) · Experimental Brain Research · doi:10.1007/bf00228106 · Cited by 45
The Ups and Downs of BDNF in Rett Syndrome
Sun, Y. E., & Wu, H. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.014 · Cited by 45
Glial Cell Line‐derived Neurotrophic Factor: the Lateral Cerebral Ventricle as a Site of Administration for Stimulation of the Substantia Nigra Dopamine System in Rats
Martin, D. A., Miller, G., Fischer, N., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01293.x · Cited by 45
Targeted Intraparenchymal Delivery of Human NGF by Gene Transfer to the Primate Basal Forebrain for 3 Months Does Not Accelerate β-Amyloid Plaque Deposition
Tuszynski, M. H., Smith, D. E., Roberts, J. A., McKay, H. M., & Mufson, E. J. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6956 · Cited by 43
Redox Modifier Genes and Pathways in Amyotrophic Lateral Sclerosis
Carter, B. J., Anklesaria, P. N., Choi, S. H., & Engelhardt, J. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2414 · Cited by 42
A Discrete Domain of the Human TrkB Receptor Defines the Binding Sites for BDNF and NT-4
Naylor, R. L., Robertson, A., Allen, S. J., Sessions, R. B., Clarke, A. R., MASON, G. G. F., Burston, J. J., Tyler, S. J., Wilcock, G. K., & Dawbarn, D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6468 · Cited by 40
Self-citation
Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway respectively in PC12 cells
Chen, Z.-Y., Chai, Y.-F., Cao, L., Huang, A., Cui, R.-Y., Lu, C.-L., & He, C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00093-8 · Cited by 40
Animal models in neurodegenerative diseases
Hirsch, É. C. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_11 · Cited by 39
Receptor-mediated transport of human recombinant nerve growth factor from olfactory bulb to forebrain cholinergic nuclei
Altar, C. A., & Bakhit, C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91077-e · Cited by 35
Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor
Fletcher, A. M., Kowalczyk, T. H., Padegimas, L., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.072 · Cited by 34
Nogo receptor antagonizes p75NTR-dependent motor neuron death
Dupuis, L., Pehar, M., Cassina, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703842105 · Cited by 34
Brain-derived neurotrophic factor and modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum
Sauer, H., Wong, V., & Björklund, A. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00019-f · Cited by 33
The development of an implantable catheter system for chronic or intermittent convection-enhanced delivery
Bienemann, A., White, E. A., Woolley, M., Castrique, E. S., Johnson, D., Wyatt, M. J., Murray, G., Taylor, H., Barua, N. U., & Gill, S. S. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.002 · Cited by 33
Self-citation
Genetics of Parkinson's disease.
Bonifati, V. (2005) · PubMed · Cited by 30
Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection
Lapchak, P. A., Araujo, D. M., Hilt, D. C., Jiao, S., Collin, F., Miyoshi, Y., Ai, Y., Zhang, Z., & Gash, D. M. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01495-9 · Cited by 30
BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress
Baj, G., & Tongiorgi, E. (2008) · Journal of Cell Science · doi:10.1242/jcs.033316 · Cited by 28
Rett syndrome: The state of clinical and basic research, and future perspectives
Matsuishi, T., Yamashita, Y., Takahashi, T., & Nagamitsu, S. (2011) · Brain and Development · doi:10.1016/j.braindev.2010.12.007 · Cited by 24
APP transgenic mice and their application to drug discovery.
Howlett, D. R. (2011) · Histology and Histopathology · doi:10.14670/hh-26.1611 · Cited by 18
Kiernan and others 2011 Amyotrophic Lateral Sclerosis - Review Article
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O. M., & Burrell, J. R. (2011) · Cited by 18
Therapy for Alzheimer's disease
Giacobini, E. (1994) · Molecular Neurobiology · doi:10.1007/bf02816110 · Cited by 18
Characterization of Two Distinct Monoclonal Antibodies Specific for Glial Cell Line‐Derived Neurotrophic Factor
Xu, R., Pong, K., Yu, Y., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041383.x · Cited by 16
Identification of a Novel Prohormone Sorting Signal-Binding Site on Carboxypeptidase E, a Regulated Secretory Pathway-Sorting Receptor
Zhang, C.-F. (1999) · Molecular Endocrinology · doi:10.1210/me.13.4.527 · Cited by 16
Quantitative Morphometric Analysis of Basal Forebrain Neurons Expressing β-Nerve Growth Factor Receptors in Normal and Alzheimer's Disease Brains
Allen, S. J., Dawbarn, D., MacGowan, S. H., et al. (1990) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107132 · Cited by 15
Self-citation
Wild-type huntingtin up-regulates BDNF transcription in Huntington's disease
Available, N. A. N. (2001) · Journal of Neurology · doi:10.1007/s004150170085 · Cited by 8
[Intrathecal infusion of brain-derived neurotrophic factor protects nigral dopaminergic neurons from degenerative changes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced monkey parkinsonian model].
Takeda, M. (1995) · PubMed · Cited by 6

Flagged first, then by citations

Research works printed but not linked: 1

Falconer, 1956, Wobbler (Wr), Mouse News Lett, 15, 23

Sorted by citations

BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson’s disease
Whone, A., Luz, M., Boca, M., Woolley, M., Mooney, L., Dharia, S., Broadfoot, J., Cronin, D., Schroers, C., Barua, N. U., et al. (2019) · Brain · doi:10.1093/brain/awz023 · Cited by 282
Self-citation
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Dendrimer-Based Drug Delivery Systems for Brain Targeting
Zhu, Y., Liu, C., & Pang, Z. (2019) · Biomolecules · doi:10.3390/biom9120790 · Cited by 220
Sodium Butyrate Prevents Memory Impairment by Re-Establishing BDNF and GDNF Expression in Experimental Pneumococcal Meningitis
Barichello, T., Generoso, J. S., Simões, L. R., Faller, C. J., Ceretta, R. A., Petronilho, F., Lopes-Borges, J., Valvassori, S. S., & Quevedo, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8914-3 · Cited by 125

See all 820

Authors: Allen, S. J., Watson, J. J., Shoemark, D. K., Barua, N. U., & Patel, N. K.
Affiliations: Frenchay Hospital (GB)
Corresponding author: Allen, Shelley J.
ORCID: Allen, Shelley J.
Shoemark, Deborah K.
Barua, Neil U.
Patel, Nikunj K.
Venue: Pharmacology & Therapeutics
Publisher: Elsevier BV
Published: 2013-05
Volume: 138
Issue: 2
Pages: 155-175
ISSN: 0163-7258 (ISSN-L)
DOI: 10.1016/j.pharmthera.2013.01.004
OpenAlex: W2006376003
Cited by: 820
References: 256
Citations by year: 2026: 42 · 2025: 68 · 2024: 80 · 2023: 74 · 2022: 64 · 2021: 68 · 2020: 49 · 2019: 56 · 2018: 66 · 2017: 53 · 2016: 71 · 2015: 48 · 2014: 63 · 2013: 17
FWCI: 6.77
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Pharmacology & Therapeutics (publishedVersion)
PubMed (publishedVersion)
Explore Bristol Research (submittedVersion)
Bristol Research (University of Bristol) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords: glial cell line-derived neurotrophic factor, nerve growth factor, brain-derived neurotrophic factor, neurotrophic factors, neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, Huntington's disease, blood-brain barrier, viral gene therapy, small molecule agonists, neurotrophin receptors
MeSH terms: Animals, Humans, Ligands, Models, Molecular, Nerve Growth Factors, Brain-Derived Neurotrophic Factor, Neurodegenerative Diseases, Glial Cell Line-Derived Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

GDNF, NGF and BDNF as therapeutic options for neurodegeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks